The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures
Abstract
Background: A variety of measures have been developed to calculate refill adherence from administrative data such as pharmacy claims databases. These measures have focused on improving the accuracy of adherence measures or clarifying the evaluation time frame. As a result, there are many measures used to assess adherence that may or may not be comparable or accurate. Objective: To compare available refill adherence measures. Methods: A systematic literature review was conducted to identify current or recently used measures of calculating adherence from administrative data. A MEDLINE search (January 1990–March 2006) was undertaken using the search terms adherence or compliance in the title combined with administrative, pharmacy, or records in any field, including subheadings medical, nursing, and hospital records. Non-English articles were excluded. Seven hundred fifteen articles were available for review. Review articles and letters were excluded from measure selection, but were included in the search terms and used to identify additional research articles. Adherence measures were excluded if they were incompletely described, produced non-numeric values, or were duplicates. Eleven refill adherence measures were identified and compared using data from the LOSE Weight (Long-term Outcomes of Sibutramine Effectiveness on Weight) study. Measures compared include Continuous Measure of Medication Acquisition (CMA); Continuous Multiple Interval Measure of Oversupply (CMOS); Medication Possession Ratio (MPR); Medication Refill Adherence (MRA); Continuous Measure of Medication Gaps (CMG); Continuous, Single Interval Measure of Medication Aquisition (CSA); Proportion of Days Covered (PDC); Refill Compliance Rate (RCR); Medication Possession Ratio, modified (MPRm); Dates Between Fills Adherence Rate (DBR); and Compliance Rate (CR). Results: The results suggest that the CMA, CMOS, MPR, and MRA are identical in terms of measuring adherence to prescription refills throughout the study period, each with a value of 63.5%; CMG and PDC are slightly lower (63.0%) and are equivalent to MRA when oversupply is truncated. CR, MPRm, RCR, and CSA result in higher adherence values of 84.4%, 86.6%, 104.8%, and 109.7%, respectively. Conclusions: Five measures produce equivalent results for measuring prescription refill adherence over the evaluation period. Of these, MRA has the fewest calculations, is easily truncated if one desires to exclude surplus medication issues, and requires the least amount of data. MRA is therefore recommended as the preferred measure of adherence using administrative data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haynes, R. B., Taylor, D. W., & Sackett, D. L. (1979) · DigitalGeorgetown (Georgetown University Library) · Cited by 2,143
(1980) · Postgraduate Medical Journal · doi:10.1136/pgmj.56.657.530 · Cited by 1,827
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
Steiner, J. F., & Prochazka, A. V. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00268-5 · Cited by 1,193
Risk Adjustment for Measuring Healthcare Outcomes
Iezzoni, L. I. (1994) · Cited by 955
Farmer, K. C. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80026-5 · Cited by 889
Weiden, P. J., Kozma, C., Grogg, A., & Locklear, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.8.886 · Cited by 621
Choo, P. W., Rand, C. S., Inui, T. S., Lee, M.-L. T., Cain, E., Cordeiro-Breault, M., Canning, C., & Platt, R. (1999) · Medical Care · doi:10.1097/00005650-199909000-00002 · Cited by 546
Risk adjustment for measuring health care outcomes
Allison, J. (1996) · Annals of Epidemiology · doi:10.1016/s1047-2797(96)90011-3 · Cited by 534
Research works printed but not linked: 7
- Enstrom I, 2000, Is compliance an issue? J Fam Pract, 49, 634
- 10.1016/S1098-3015(10)60929-1 · doi:10.1016/s1098-3015(10)60929-1
- Porter JA, 2004, Am J Manag Care, 10, 369
- Skaer TL, 1993, Clin Ther, 15, 905
- Hamilton RA, 1992, Am J Hosp Pharm, 49, 1691
- Sturgess IK, 2000, Pharmaceut J, 265, R35
- Thiebaud P, 2005, Am J Manag Care, 11, 670
Cited by
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Medication adherence measures: An overview
Lam, W. Y., & Fresco, P. (2015) · BioMed Research International · doi:10.1155/2015/217047 · Cited by 1,308
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Good and poor adherence: optimal cut-point for adherence measures using administrative claims data.
Karve, S., Cleves, M. A., Helm, M., Hudson, T. J., West, D. S., & Martin, B. C. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903126833 · Cited by 620
Comparison of drug adherence rates among patients with seven different medical conditions
Briesacher, B. A., Andrade, S. E., Fouayzi, H., & Chan, K. A. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.4.437 · Cited by 587
Medication adherence and the risk of severe asthma exacerbations: a systematic review
Engelkes, M., Janssens, H. M., de Jongste, J. C., Sturkenboom, M. C. J. M., & Verhamme, K. M. C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00075614 · Cited by 534
Kane, J. M., Kishimoto, T., & Correll, C. U. (2013) · World Psychiatry · doi:10.1002/wps.20060 · Cited by 520
Cost Sharing and Adherence to Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
Dusetzina, S. B., Winn, A. N., Abel, G. A., Huskamp, H. A., & Keating, N. L. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.52.9123 · Cited by 500
Raebel, M. A., Schmittdiel, J., Karter, A. J., Konieczny, J. L., & Steiner, J. F. (2013) · Medical Care · doi:10.1097/mlr.0b013e31829b1d2a · Cited by 485
Self-citationPatient Characteristics Associated with Medication Adherence
Rolnick, S. J., Pawloski, P. A., Hedblom, B. D., Asche, S. E., & Bruzek, R. J. (2013) · Clinical Medicine & Research · doi:10.3121/cmr.2013.1113 · Cited by 481
Determinants of Adherence to Diabetes Medications: Findings From a Large Pharmacy Claims Database
Kirkman, M. S., Rowan-Martin, M. T., Levin, R., Fonseca, V. A., Schmittdiel, J. A., Herman, W. H., & Aubert, R. E. (2015) · Diabetes Care · doi:10.2337/dc14-2098 · Cited by 388
Neugut, A. I., Subar, M., Wilde, E. T., Stratton, S., Brouse, C. H., Hillyer, G. C., Grann, V. R., & Hershman, D. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3179 · Cited by 354
Beliefs about medicines predict refill adherence to inhaled corticosteroids
Menckeberg, T. T., Bouvy, M. L., Bracke, M., Kaptein, A. A., Leufkens, H. G., Raaijmakers, J. A. M., & Horne, R. (2008) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2007.07.016 · Cited by 345
Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann, D. M., Woodward, M., Muntner, P., Falzon, L., & Kronish, I. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1p150 · Cited by 329
van den Bemt, B. J., Zwikker, H. E., & van den Ende, C. H. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.23 · Cited by 320
Doctor–Patient Communication, Health-Related Beliefs, and Adherence in Glaucoma
Friedman, D. S., Hahn, S. R., Gelb, L., Tan, J., Shah, S. N., Kim, E. E., Zimmerman, T. J., & Quigley, H. A. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.11.023 · Cited by 297
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review
De Vera, M. A., Bhole, V., Burns, L. C., & Lacaille, D. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12339 · Cited by 289
Impact of Medication Nonadherence on Hospitalizations and Mortality in Heart Failure
Fitzgerald, A. A., Powers, J. D., Ho, P. M., Maddox, T. M., Peterson, P. N., Allen, L. A., Masoudi, F. A., Magid, D. J., & Havranek, E. P. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.04.011 · Cited by 284
The Diabetes Mellitus Medication Choice Decision Aid: A Randomized Trial
Mullan, R. J., Montori, V. M., Shah, N. D., Christianson, T. J. H., Bryant, S. C., Guyatt, G. H., Perestelo-Perez, L. I., Stroebel, R. J., Yawn, B. P., Yapuncich, V., et al. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.293 · Cited by 283
Friedman, D. S., Quigley, H. A., Gelb, L., Tan, J., Margolis, J., Shah, S. N., Kim, E. E., Zimmerman, T., & Hahn, S. R. (2007) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-0290 · Cited by 281
Risk Factors for Nonadherence to Antihypertensive Treatment
Gupta, P., Patel, P., Štrauch, B., Lai, F. Y., Akbarov, A., Marešová, V., White, C. M. J., Petrák, O., Gulsin, G. S., Patel, V., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08729 · Cited by 256
Hovinga, C. A., Asato, M. R., Manjunath, R., Wheless, J. W., Phelps, S. J., Sheth, R. D., Pina-Garza, J. E., Zingaro, W. M., & Haskins, L. S. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2008.03.009 · Cited by 253
Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs
Dragomir, A., Côté, R., Roy, L., Blais, L., Lalonde, L., Bérard, A., & Perreault, S. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181d567bd · Cited by 221
Martin, B. C., Wiley-Exley, E. K., Richards, S., Domino, M. E., Carey, T. S., & Sleath, B. L. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1k671 · Cited by 226
Effectiveness of pharmacist intervention for asthma control improvement
Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J. P., & Brusselle, G. (2008) · European Respiratory Journal · doi:10.1183/09031936.00112007 · Cited by 218
Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation
Turakhia, M. P., Santangeli, P., Winkelmayer, W. C., Xu, X., Ullal, A. J., Than, C. T., Schmitt, S., Holmes, T. H., Frayne, S. M., Phibbs, C. S., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.060 · Cited by 208
Verbrugghe, M., Verhaeghe, S., Lauwaert, K., Beeckman, D., & Van Hecke, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.12.014 · Cited by 202
Effect of Reminder Devices on Medication Adherence: The REMIND Randomized Clinical Trial
Choudhry, N. K., Krumme, A. A., Ercole, P. M., Girdish, C., Tong, A. Y., Khan, N. F., Brennan, T. A., Matlin, O. S., Shrank, W. H., & Franklin, J. M. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.9627 · Cited by 199
Factors That Affect Adherence to Bipolar Disorder Treatments: A Stated-Preference Approach
Johnson, F. R., Özdemir, S., Manjunath, R., Hauber, A. B., Burch, S. P., & Thompson, T. R. (2007) · Medical Care · doi:10.1097/mlr.0b013e318040ad90 · Cited by 164
Longitudinal effects of medication nonadherence on glycemic control
Egede, L. E., Gebregziabher, M., Echols, C., & Lynch, C. P. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014526362 · Cited by 146
Mehuys, E., Van Bortel, L., De Bolle, L., Van Tongelen, I., Annemans, L., Remon, J.-P., & Giri, M. (2011) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2010.01218.x · Cited by 139
Sattler, E. L. P., Lee, J. S., & Perri, M. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0074-z · Cited by 127
Sinnott, S.-J., Buckley, C., O′Riordan, D., Bradley, C., & Whelton, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064914 · Cited by 124
Adherence to Statins, Subsequent Healthcare Costs, and Cardiovascular Hospitalizations
Pittman, D. G., Chen, W., Bowlin, S. J., & Foody, J. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.01.052 · Cited by 123
Drug adherence in hypertension: from methodological issues to cardiovascular outcomes
Hamdidouche, I., Jullien, V., Boutouyrie, P., Billaud, E., Azizi, M., & Laurent, S. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001299 · Cited by 111
Keyloun, K. R., Hansen, R. N., Hepp, Z., Gillard, P., Thase, M. E., & Devine, E. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0417-0 · Cited by 99
Research and scholarly methods: Measuring medication adherence
Shah, K. K., Touchette, D. R., & Marrs, J. C. (2023) · JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1771 · Cited by 69
Tamblyn, R., Reidel, K., Huang, A., Taylor, L., Winslade, N., Bartlett, G., Grad, R., Jacques, A., Dawes, M., Larochelle, P., et al. (2010) · Medical Decision Making · doi:10.1177/0272989x09342752 · Cited by 44
Sicras-Mainar, A., Maurino, J., Cordero, L., Blanca-Tamayo, M., & Navarro-Artieda, R. (2012) · Annals of General Psychiatry · doi:10.1186/1744-859x-11-22 · Cited by 11
Dang, T. H., Wickramasinghe, N., Jayaraman, P. P., Burbury, K., Alexander, M., Whitechurch, A., Dyer, M., Quinn, S., Forkan, A. R. M., & Schofield, P. (2025) · JMIR Formative Research · doi:10.2196/65302 · Cited by 9
Metadata
- Authors
- Hess, L. M., Raebel, M. A., Conner, D. A., & Malone, D. C.
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2006-07
- Volume
- 40
- Issue
- 7-8
- Pages
- 1280-1288
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2157029647
- Cited by
- 756
- References
- 30
- FWCI
- 11.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.